{"id":"testosterone-gel-1","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Application site reactions (erythema, pruritus)"},{"rate":"5-10","effect":"Acne"},{"rate":"1-5","effect":"Polycythemia"},{"rate":"1-3","effect":"Gynecomastia"},{"rate":"2-5","effect":"Headache"},{"rate":"1-3","effect":"Mood changes/irritability"}]},"_chembl":null,"_dailymed":{"setId":"7d655d6d-01da-488c-bd4e-c7fbe0ace38c","title":"TESTOSTERONE GEL, 1% GEL [ENCUBE ETHICALS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Testosterone is applied topically as a 1% gel formulation, allowing percutaneous absorption into systemic circulation. It binds to androgen receptors throughout the body to restore physiological testosterone levels in hypogonadal patients, promoting development and maintenance of male sexual characteristics, muscle mass, bone density, and other androgen-dependent functions.","oneSentence":"Testosterone gel delivers exogenous testosterone through transdermal absorption to replace deficient endogenous testosterone and restore normal androgen levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:08:15.336Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Testosterone replacement therapy in adult males with hypogonadism"}]},"trialDetails":[{"nctId":"NCT04675788","phase":"PHASE4","title":"Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-09-02","conditions":"Long QT Syndrome, Abnormalities, Drug-Induced","enrollment":73},{"nctId":"NCT05617885","phase":"PHASE1","title":"Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Praful Ravi, MB BCHir, MRCP","startDate":"2023-08-09","conditions":"Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer","enrollment":9},{"nctId":"NCT06305598","phase":"PHASE1","title":"Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2024-12-19","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":14},{"nctId":"NCT06733350","phase":"PHASE4","title":"Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance","status":"SUSPENDED","sponsor":"Roswell Park Cancer Institute","startDate":"2025-01-15","conditions":"Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8","enrollment":600},{"nctId":"NCT06059118","phase":"PHASE2","title":"Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2023-10-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT06130449","phase":"EARLY_PHASE1","title":"Testosterone and Neural Function","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-04-01","conditions":"Spinal Cord Injury","enrollment":15},{"nctId":"NCT06084338","phase":"PHASE2","title":"Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-12-14","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT05669664","phase":"PHASE2","title":"Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-07-20","conditions":"Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma","enrollment":21},{"nctId":"NCT03734653","phase":"EARLY_PHASE1","title":"Testosterone Therapy in Castration Resistant Prostate Cancer","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2019-01-18","conditions":"Prostate Cancer, Castration-Resistant Prostate Cancer","enrollment":30},{"nctId":"NCT04807894","phase":"PHASE4","title":"Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo","status":"RECRUITING","sponsor":"Maimonides Medical Center","startDate":"2020-11-01","conditions":"Recurrent Urinary Tract Infection, Vaginal Atrophy, Postmenopausal Disorder","enrollment":100},{"nctId":"NCT06922318","phase":"PHASE2","title":"The COSMYC Trial (COmbined Suppression of MYC)","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2025-08-19","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":50},{"nctId":"NCT02256865","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2014-10","conditions":"Insulin Resistance","enrollment":40},{"nctId":"NCT06455969","phase":"PHASE4","title":"Adaptions and Resiliency to Multi-Stressor OpeRations","status":"RECRUITING","sponsor":"Bradley Nindl","startDate":"2024-07-15","conditions":"Musculoskeletal Injury, Hypogonadism","enrollment":120},{"nctId":"NCT06247267","phase":"","title":"The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population","status":"RECRUITING","sponsor":"Walter Reed National Military Medical Center","startDate":"2021-03-09","conditions":"Hypogonadism, Gender Identity Dysphoria","enrollment":75},{"nctId":"NCT06253702","phase":"PHASE4","title":"Brain Blood Flow Responses to Stress: Sex Differences","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2024-07-24","conditions":"Cerebrovascular Disorders","enrollment":22},{"nctId":"NCT05381831","phase":"PHASE4","title":"Natesto Spermatogenesis Reboot","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-06-01","conditions":"Hypogonadism, Male","enrollment":13},{"nctId":"NCT06351501","phase":"PHASE3","title":"Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering from Gender Dysphoria","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-06-25","conditions":"Gender Dysphoria","enrollment":60},{"nctId":"NCT02432261","phase":"PHASE1","title":"Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men","status":"COMPLETED","sponsor":"Kimberly Myer","startDate":"2015-04","conditions":"Healthy","enrollment":44},{"nctId":"NCT02938923","phase":"PHASE3","title":"Starting a Testosterone and Exercise Program After Hip Injury","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-03-05","conditions":"Hip Fracture, Frailty, Sarcopenia","enrollment":129},{"nctId":"NCT06393634","phase":"EARLY_PHASE1","title":"Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration","status":"COMPLETED","sponsor":"Sports Medicine Research and Testing Laboratory","startDate":"2024-11-27","conditions":"Healthy","enrollment":14},{"nctId":"NCT04558567","phase":"PHASE4","title":"Vogelxo(R) ABPM Study in Hypogandal Men","status":"COMPLETED","sponsor":"Upsher-Smith Laboratories","startDate":"2020-08-28","conditions":"Hypogonadism, Male","enrollment":122},{"nctId":"NCT02758431","phase":"NA","title":"Cardiovascular Outcomes of Low Testosterone","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2016-07-01","conditions":"Hypogonadism","enrollment":232},{"nctId":"NCT00645658","phase":"NA","title":"Testosterone Replacement Therapy in Advanced Chronic Kidney Disease","status":"COMPLETED","sponsor":"Palo Alto Veterans Institute for Research","startDate":"2007-08","conditions":"Kidney Failure, Kidney Diseases","enrollment":17},{"nctId":"NCT02418572","phase":"PHASE3","title":"Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2015-04","conditions":"Infertility, Poor Ovarian Response","enrollment":290},{"nctId":"NCT05478746","phase":"NA","title":"Effects of Flourish HEC on Localized Provoked Vulvodynia","status":"COMPLETED","sponsor":"Vaginal Biome Science","startDate":"2022-09-26","conditions":"Vulvodynia, Vestibulodynia, Vulvar Diseases","enrollment":7},{"nctId":"NCT00467987","phase":"NA","title":"Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism","status":"TERMINATED","sponsor":"University at Buffalo","startDate":"2007-06-01","conditions":"Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism","enrollment":47},{"nctId":"NCT05586802","phase":"PHASE3","title":"Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome","status":"RECRUITING","sponsor":"Georgios Papadakis","startDate":"2023-03-21","conditions":"Klinefelter Syndrome","enrollment":150},{"nctId":"NCT00587431","phase":"PHASE2","title":"Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-07","conditions":"Prostate Cancer","enrollment":102},{"nctId":"NCT03345797","phase":"PHASE1","title":"Evaluation of Testosterone Nasal Gel in Hypogonadal Boys","status":"TERMINATED","sponsor":"Acerus Biopharma Inc.","startDate":"2018-03-01","conditions":"Hypogonadism","enrollment":8},{"nctId":"NCT05825092","phase":"PHASE2","title":"Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2023-07-21","conditions":"Critical Illness","enrollment":600},{"nctId":"NCT05862519","phase":"NA","title":"A Clinical Study to Evaluate the Efficacy of Four Supplements on Improving Readiness for Intimacy","status":"UNKNOWN","sponsor":"906 CMVI Holdings","startDate":"2023-03-14","conditions":"Libido, Intimacy, Gastrointestinal Issues","enrollment":36},{"nctId":"NCT00694733","phase":"NA","title":"Regulation of Cortisol Metabolism and Fat Patterning","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2005-05","conditions":"Obesity, Menopausal Syndrome","enrollment":140},{"nctId":"NCT04274894","phase":"PHASE4","title":"A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-05-12","conditions":"Hypogonadism","enrollment":246},{"nctId":"NCT04492553","phase":"PHASE2","title":"Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality","status":"COMPLETED","sponsor":"Lars Møller Pedersen","startDate":"2021-04-01","conditions":"Hypogonadism","enrollment":7},{"nctId":"NCT00163566","phase":"PHASE2","title":"Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80","status":"COMPLETED","sponsor":"ASCEND Therapeutics","startDate":"2004-10","conditions":"Hypogonadism, Late Onset Hypogonadism, Low Testosterone","enrollment":128},{"nctId":"NCT02349386","phase":"PHASE2","title":"Maintaining Suppression of Testosterone With Transdermal Estradiol Gel","status":"TERMINATED","sponsor":"BHR Pharma, LLC","startDate":"2015-07","conditions":"Cancer of the Prostate","enrollment":34},{"nctId":"NCT00612742","phase":"PHASE3","title":"Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women","status":"COMPLETED","sponsor":"BioSante Pharmaceuticals","startDate":"2008-01","conditions":"Hypoactive Sexual Desire Disorder","enrollment":3656},{"nctId":"NCT01585831","phase":"NA","title":"Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2012-03","conditions":"Klinefelter Syndrome, XXY Syndrome","enrollment":48},{"nctId":"NCT04819204","phase":"NA","title":"Testosterone and Neurovascular Control in Humans","status":"UNKNOWN","sponsor":"Western University, Canada","startDate":"2021-06","conditions":"Healthy","enrollment":20},{"nctId":"NCT04602143","phase":"NA","title":"Effect of Testosterone Pretreatment in POR","status":"COMPLETED","sponsor":"Hanoi Medical University","startDate":"2018-02-16","conditions":"Infertility","enrollment":165},{"nctId":"NCT00112151","phase":"PHASE2","title":"TEAM: Testosterone Supplementation and Exercise in Elderly Men","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2005-01","conditions":"Healthy","enrollment":167},{"nctId":"NCT02991209","phase":"PHASE2, PHASE3","title":"Study of Testosterone vs Placebo in Testicular Cancer Survivors","status":"COMPLETED","sponsor":"Mikkel Bandak","startDate":"2016-11","conditions":"Metabolic Syndrome, Testicular Cancer, Leydig Cell Failure in Adult","enrollment":69},{"nctId":"NCT02147964","phase":"PHASE2","title":"ITT-5 Mechanisms of Spermatogenesis in Man","status":"WITHDRAWN","sponsor":"University of Washington","startDate":"2019-06","conditions":"Gonadotropin Deficiency","enrollment":""},{"nctId":"NCT03000127","phase":"PHASE2","title":"Testosterone for Fatigue in Men With MS","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2018-07-01","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT01364623","phase":"PHASE1","title":"PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women","status":"COMPLETED","sponsor":"Acerus Pharmaceuticals Corporation","startDate":"2011-09","conditions":"Female Sexual Dysfunction","enrollment":24},{"nctId":"NCT00114114","phase":"NA","title":"Dose-Response of Gonadal Steroids and Bone Turnover in Older Men","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-09","conditions":"Healthy Volunteers","enrollment":177},{"nctId":"NCT02513940","phase":"PHASE4","title":"Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes","status":"COMPLETED","sponsor":"Indiana University","startDate":"2016-05","conditions":"Long QT Syndrome","enrollment":14},{"nctId":"NCT03378713","phase":"PHASE3","title":"Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM)","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2017-08-07","conditions":"Infertility, Female","enrollment":63},{"nctId":"NCT02937740","phase":"PHASE4","title":"Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™","status":"COMPLETED","sponsor":"Acerus Pharmaceuticals Corporation","startDate":"2016-10","conditions":"Hypogonadism","enrollment":117},{"nctId":"NCT03967964","phase":"PHASE1","title":"Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2015-11-20","conditions":"Pharmacokinetics, Hormone Deficiency","enrollment":46},{"nctId":"NCT03783988","phase":"PHASE1","title":"Study With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to Glucocorticoids","status":"UNKNOWN","sponsor":"Trophea Development AB","startDate":"2019-01-15","conditions":"Skin Atrophy","enrollment":10},{"nctId":"NCT00104572","phase":"PHASE2","title":"Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2004-03","conditions":"Hypogonadism, Diabetes, Sarcopenia","enrollment":44},{"nctId":"NCT00631137","phase":"NA","title":"Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2008-01","conditions":"Brain and Central Nervous System Tumors, Musculoskeletal Complications","enrollment":1},{"nctId":"NCT02847806","phase":"PHASE3","title":"Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man","status":"COMPLETED","sponsor":"University Hospital, Caen","startDate":"2008-01","conditions":"Hypogonadism","enrollment":6},{"nctId":"NCT01403116","phase":"PHASE3","title":"Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men","status":"COMPLETED","sponsor":"Clarus Therapeutics, Inc.","startDate":"2011-07","conditions":"Male Hypogonadism","enrollment":325},{"nctId":"NCT01607658","phase":"PHASE2","title":"Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder","status":"COMPLETED","sponsor":"Acerus Pharmaceuticals Corporation","startDate":"2012-05","conditions":"Female Orgasmic Disorder","enrollment":253},{"nctId":"NCT03619330","phase":"PHASE4","title":"Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2014-12","conditions":"Hypogonadism, Obesity","enrollment":30},{"nctId":"NCT00190060","phase":"PHASE4","title":"Study of The Effects of Testosterone in Frail Elderly Men","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"2004-10","conditions":"Frailty, Sarcopenia","enrollment":262},{"nctId":"NCT00805207","phase":"NA","title":"Sex Steroids, Sleep, and Metabolic Dysfunction in Women","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2007-09","conditions":"Polycystic Ovary Syndrome (PCOS), Obstructive Sleep Apnea, Obesity","enrollment":61},{"nctId":"NCT02667561","phase":"PHASE1","title":"Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%","status":"WITHDRAWN","sponsor":"Biolab Sanus Farmaceutica","startDate":"2017-07","conditions":"Post-menopausal Period","enrollment":""},{"nctId":"NCT00957801","phase":"PHASE4","title":"Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2009-03","conditions":"Sarcopenia","enrollment":29},{"nctId":"NCT01686828","phase":"PHASE1, PHASE2","title":"T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin","status":"COMPLETED","sponsor":"University of Washington","startDate":"2013-06","conditions":"Insulin Resistance, Type 2 Diabetes Mellitus, Obesity","enrollment":53},{"nctId":"NCT00345969","phase":"PHASE3","title":"Exercise and Testosterone Therapy in Elderly Men With Physical Frailty","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2004-11","conditions":"Physical Frailty, Hip Fracture, Elective Hip Replacement","enrollment":25},{"nctId":"NCT01133548","phase":"PHASE1","title":"Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males","status":"COMPLETED","sponsor":"AbbVie","startDate":"2010-05","conditions":"Hypogonadism","enrollment":62},{"nctId":"NCT01130298","phase":"PHASE1","title":"An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier","status":"COMPLETED","sponsor":"AbbVie","startDate":"2010-05","conditions":"Healthy","enrollment":24},{"nctId":"NCT00194675","phase":"PHASE4","title":"TRADE-Testosterone Replacement and Dutasteride Effectiveness","status":"COMPLETED","sponsor":"University of Washington","startDate":"2005-03","conditions":"Hypogonadism, Benign Prostatic Hyperplasia","enrollment":53},{"nctId":"NCT02149264","phase":"PHASE3","title":"A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2014-07","conditions":"Adult Male Hypogonadism","enrollment":160},{"nctId":"NCT01327495","phase":"PHASE2, PHASE3","title":"PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate","status":"COMPLETED","sponsor":"University of Washington","startDate":"2011-10","conditions":"Healthy","enrollment":62},{"nctId":"NCT00522431","phase":"PHASE3","title":"A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2007-08","conditions":"Hypogonadism","enrollment":149},{"nctId":"NCT03289559","phase":"NA","title":"Effects of Testosterone and Fat Utilization","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2006-01-01","conditions":"Healthy, Volunteers","enrollment":13},{"nctId":"NCT03281187","phase":"PHASE3","title":"Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.","status":"UNKNOWN","sponsor":"FBM Industria Brasileira Ltda","startDate":"2018-07-16","conditions":"Hypogonadism","enrollment":228},{"nctId":"NCT01464879","phase":"PHASE2","title":"A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2011-12","conditions":"Hypogonadal Males","enrollment":20},{"nctId":"NCT01370369","phase":"PHASE2","title":"Efficacy, Pharmacokinetics and Safety of Testosterone","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2011-05","conditions":"Testicular Hypogonadism","enrollment":20},{"nctId":"NCT02317640","phase":"PHASE1, PHASE2","title":"TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males","status":"UNKNOWN","sponsor":"Kessler Foundation","startDate":"2017-03-15","conditions":"Spinal Cord Injury","enrollment":56},{"nctId":"NCT00287586","phase":"PHASE4","title":"Testosterone Replacement in Older Men and Atherosclerosis Progression","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2004-09","conditions":"Hypogonadism, Atherosclerosis","enrollment":308},{"nctId":"NCT00512707","phase":"PHASE4","title":"Effect of Testosterone in Men With Erectile Dysfunction","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-11","conditions":"Erectile Dysfunction, Testosterone Deficiency, Diabetes","enrollment":140},{"nctId":"NCT03118479","phase":"PHASE1","title":"Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2010-05","conditions":"Hypogonadotropic Hypogonadism, Kallmann Syndrome","enrollment":7},{"nctId":"NCT00438321","phase":"PHASE1","title":"Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2006-09","conditions":"Metabolic Syndrome","enrollment":66},{"nctId":"NCT02549690","phase":"NA","title":"Testosterone Gel in Poor Responders Undergoing IVF","status":"WITHDRAWN","sponsor":"Vietnam National University","startDate":"2015-09","conditions":"Infertility","enrollment":""},{"nctId":"NCT00240981","phase":"PHASE4","title":"TOM: Testosterone in Older Men With Sarcopenia","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2005-01","conditions":"Sarcopenia, Hypogonadism, Muscular Diseases","enrollment":209},{"nctId":"NCT00586898","phase":"PHASE2","title":"Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2001-07","conditions":"Prostate, Cancer, Hormonal Cycling","enrollment":36},{"nctId":"NCT00839319","phase":"PHASE1, PHASE2","title":"HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-03","conditions":"Healthy Males","enrollment":59},{"nctId":"NCT00254553","phase":"PHASE2","title":"A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-07","conditions":"Hypogonadism","enrollment":150},{"nctId":"NCT00706719","phase":"PHASE2","title":"To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2008-06","conditions":"Secondary Hypogonadism","enrollment":17},{"nctId":"NCT00440440","phase":"PHASE4","title":"Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes","status":"WITHDRAWN","sponsor":"Diabetes Center of the Southwest","startDate":"2009-08","conditions":"Hypogonadism, Diabetes","enrollment":""},{"nctId":"NCT00848497","phase":"EARLY_PHASE1","title":"Testosterone for Penile Rehabilitation After Radical Prostatectomy","status":"TERMINATED","sponsor":"Mohit Khera","startDate":"2007-11","conditions":"Hypogonadism, Erectile Dysfunction","enrollment":3},{"nctId":"NCT01292785","phase":"","title":"Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-01","conditions":"Gender Identity Disorder","enrollment":80},{"nctId":"NCT00193661","phase":"PHASE2","title":"Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2002-08","conditions":"Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP)","enrollment":""},{"nctId":"NCT00229593","phase":"PHASE1","title":"NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel","status":"COMPLETED","sponsor":"University of Washington","startDate":"2005-09","conditions":"Contraception","enrollment":140},{"nctId":"NCT00969163","phase":"PHASE1","title":"A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-10","conditions":"Skin Androgenization","enrollment":30},{"nctId":"NCT02110368","phase":"PHASE3","title":"Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions","status":"COMPLETED","sponsor":"Amneal Pharmaceuticals, LLC","startDate":"2014-03","conditions":"Primary Hypogonadism, Hypogonadotropic Hypogonadism","enrollment":32},{"nctId":"NCT00515112","phase":"PHASE2","title":"Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2007-07","conditions":"Prostate Cancer","enrollment":6},{"nctId":"NCT01160328","phase":"PHASE1","title":"Influence of Male Hormones on Regional Fat Metabolism","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-06","conditions":"Obesity","enrollment":39},{"nctId":"NCT00185198","phase":"PHASE3","title":"Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-09","conditions":"Androgens (Deficiency), Male","enrollment":363},{"nctId":"NCT01215292","phase":"PHASE1, PHASE2","title":"ITT4 Intratesticular Hormonal Milieu in Man (ITT4)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2011-01","conditions":"Healthy Males","enrollment":46},{"nctId":"NCT00490555","phase":"PHASE2, PHASE3","title":"PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT01386567","phase":"PHASE2","title":"A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2011-07","conditions":"Hypogonadism, Low Testosterone","enrollment":48},{"nctId":"NCT01344564","phase":"NA","title":"Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide","status":"COMPLETED","sponsor":"Urology of Virginia","startDate":"2011-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT01786473","phase":"PHASE3","title":"Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism","status":"UNKNOWN","sponsor":"Laboratoires Besins International","startDate":"2012-12","conditions":"Hypogonadism","enrollment":240},{"nctId":"NCT01235754","phase":"PHASE3","title":"Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)","status":"COMPLETED","sponsor":"BioSante Pharmaceuticals","startDate":"2010-10","conditions":"Hypoactive Sexual Desire Disorder","enrollment":626}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Androgel 1%","T gel","Testosterone gel","AndroGel"],"phase":"marketed","status":"active","brandName":"Testosterone gel 1%","genericName":"Testosterone gel 1%","companyName":"University of Colorado, Denver","companyId":"university-of-colorado-denver","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Testosterone gel delivers exogenous testosterone through transdermal absorption to replace deficient endogenous testosterone and restore normal androgen levels. Used for Testosterone replacement therapy in adult males with hypogonadism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}